APO RESEARCH · REPORT
Molecular Microbiology
Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.
Product & engineering
Understand the product.
Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.
Selected research
Market Structure
Global Molecular Microbiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.
Global Molecular Microbiology key players include Roche, Qiagen, Illumina, Abbott, BioMerieux, etc. Global top five manufacturers hold a share about 65%. North America is the largest market, with a share about 50%, followed by Europe, with a share about 30 percent. In terms of product, Quantitative PCR Detection Diagnostic Kits is the largest segment, with a share about 45%. And in terms of application, the largest application is Human, followed by Veterinary.
This report provides an overview of the global Molecular Microbiology market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Molecular Microbiology and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Molecular Microbiology sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Molecular Microbiology market size, projected growth trends, production technologies, key applications, and end-use industries.
Molecular Microbiology Segment by Company
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Molecular Microbiology Segment by Type
Quantitative PCR Detection Diagnostic Kits
Pathogenic Microorganisms Diagnostic Kits
Other
Molecular Microbiology Segment by Application
Human
Veterinary
Molecular Microbiology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Microbiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Microbiology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Microbiology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Molecular Microbiology market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Microbiology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Microbiology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Molecular Microbiology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Quantitative PCR Detection Diagnostic Kits
- Pathogenic Microorganisms Diagnostic Kits
- Other
Applications
- Human
- Veterinary
Companies covered
- Roche
- Qiagen
- Illumina
- Abbott
- Hologic
- BioMerieux
- Danaher (Cepheid)
- Myriad Genetics
- DAAN Gene
- Agilent
- Genomic Health
- BD
- Foundation Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Molecular Microbiology Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Molecular Microbiology Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Molecular Microbiology Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Molecular Microbiology Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Molecular Microbiology Market Dynamics
- 2.1 Molecular Microbiology Industry Trends
- 2.2 Molecular Microbiology Industry Drivers
- 2.3 Molecular Microbiology Industry Opportunities and Challenges
- 2.4 Molecular Microbiology Industry Restraints
3 Molecular Microbiology Market by Manufacturers
- 3.1 Global Molecular Microbiology Revenue by Manufacturers (2021-2026)
- 3.2 Global Molecular Microbiology Sales by Manufacturers (2021-2026)
- 3.3 Global Molecular Microbiology Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Molecular Microbiology Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Molecular Microbiology Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Molecular Microbiology Manufacturers, Product Type & Application
- 3.7 Global Molecular Microbiology Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Molecular Microbiology Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Molecular Microbiology Players Market Share by Revenue in 2025
- 3.8.3 2025 Molecular Microbiology Tier 1, Tier 2, and Tier 3
4 Molecular Microbiology Market by Type
- 4.1 Molecular Microbiology Type Introduction
- 4.1.1 Quantitative PCR Detection Diagnostic Kits
- 4.1.2 Pathogenic Microorganisms Diagnostic Kits
- 4.1.3 Other
- 4.2 Global Molecular Microbiology Sales by Type
- 4.2.1 Global Molecular Microbiology Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Molecular Microbiology Sales by Type (2021-2032)
- 4.2.3 Global Molecular Microbiology Sales Market Share by Type (2021-2032)
- 4.3 Global Molecular Microbiology Revenue by Type
- 4.3.1 Global Molecular Microbiology Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Molecular Microbiology Revenue by Type (2021-2032)
- 4.3.3 Global Molecular Microbiology Revenue Market Share by Type (2021-2032)
5 Molecular Microbiology Market by Application
- 5.1 Molecular Microbiology Application Introduction
- 5.1.1 Human
- 5.1.2 Veterinary
- 5.2 Global Molecular Microbiology Sales by Application
- 5.2.1 Global Molecular Microbiology Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Molecular Microbiology Sales by Application (2021-2032)
- 5.2.3 Global Molecular Microbiology Sales Market Share by Application (2021-2032)
- 5.3 Global Molecular Microbiology Revenue by Application
- 5.3.1 Global Molecular Microbiology Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Molecular Microbiology Revenue by Application (2021-2032)
- 5.3.3 Global Molecular Microbiology Revenue Market Share by Application (2021-2032)
6 Global Molecular Microbiology Sales by Region
- 6.1 Global Molecular Microbiology Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Molecular Microbiology Sales by Region (2021-2032)
- 6.2.1 Global Molecular Microbiology Sales by Region (2021-2026)
- 6.2.2 Global Molecular Microbiology Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Molecular Microbiology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Molecular Microbiology Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Molecular Microbiology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Molecular Microbiology Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Molecular Microbiology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Molecular Microbiology Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Molecular Microbiology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Molecular Microbiology Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Molecular Microbiology Revenue by Region
- 7.1 Global Molecular Microbiology Revenue by Region
- 7.1.1 Global Molecular Microbiology Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Molecular Microbiology Revenue by Region (2021-2026)
- 7.1.3 Global Molecular Microbiology Revenue by Region (2027-2032)
- 7.1.4 Global Molecular Microbiology Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Molecular Microbiology Revenue (2021-2032)
- 7.2.2 North America Molecular Microbiology Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Molecular Microbiology Revenue (2021-2032)
- 7.3.2 Europe Molecular Microbiology Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Molecular Microbiology Revenue (2021-2032)
- 7.4.2 Asia-Pacific Molecular Microbiology Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Molecular Microbiology Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Molecular Microbiology Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Roche
- 8.1.1 Roche Company Information
- 8.1.2 Roche Business Overview
- 8.1.3 Roche Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Roche Molecular Microbiology Product Portfolio
- 8.1.5 Roche Recent Developments
- 8.2 Qiagen
- 8.2.1 Qiagen Company Information
- 8.2.2 Qiagen Business Overview
- 8.2.3 Qiagen Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Qiagen Molecular Microbiology Product Portfolio
- 8.2.5 Qiagen Recent Developments
- 8.3 Illumina
- 8.3.1 Illumina Company Information
- 8.3.2 Illumina Business Overview
- 8.3.3 Illumina Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Illumina Molecular Microbiology Product Portfolio
- 8.3.5 Illumina Recent Developments
- 8.4 Abbott
- 8.4.1 Abbott Company Information
- 8.4.2 Abbott Business Overview
- 8.4.3 Abbott Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Abbott Molecular Microbiology Product Portfolio
- 8.4.5 Abbott Recent Developments
- 8.5 Hologic
- 8.5.1 Hologic Company Information
- 8.5.2 Hologic Business Overview
- 8.5.3 Hologic Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hologic Molecular Microbiology Product Portfolio
- 8.5.5 Hologic Recent Developments
- 8.6 BioMerieux
- 8.6.1 BioMerieux Company Information
- 8.6.2 BioMerieux Business Overview
- 8.6.3 BioMerieux Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 BioMerieux Molecular Microbiology Product Portfolio
- 8.6.5 BioMerieux Recent Developments
- 8.7 Danaher (Cepheid)
- 8.7.1 Danaher (Cepheid) Company Information
- 8.7.2 Danaher (Cepheid) Business Overview
- 8.7.3 Danaher (Cepheid) Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Danaher (Cepheid) Molecular Microbiology Product Portfolio
- 8.7.5 Danaher (Cepheid) Recent Developments
- 8.8 Myriad Genetics
- 8.8.1 Myriad Genetics Company Information
- 8.8.2 Myriad Genetics Business Overview
- 8.8.3 Myriad Genetics Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Myriad Genetics Molecular Microbiology Product Portfolio
- 8.8.5 Myriad Genetics Recent Developments
- 8.9 DAAN Gene
- 8.9.1 DAAN Gene Company Information
- 8.9.2 DAAN Gene Business Overview
- 8.9.3 DAAN Gene Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 DAAN Gene Molecular Microbiology Product Portfolio
- 8.9.5 DAAN Gene Recent Developments
- 8.10 Agilent
- 8.10.1 Agilent Company Information
- 8.10.2 Agilent Business Overview
- 8.10.3 Agilent Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Agilent Molecular Microbiology Product Portfolio
- 8.10.5 Agilent Recent Developments
- 8.11 Genomic Health
- 8.11.1 Genomic Health Company Information
- 8.11.2 Genomic Health Business Overview
- 8.11.3 Genomic Health Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Genomic Health Molecular Microbiology Product Portfolio
- 8.11.5 Genomic Health Recent Developments
- 8.12 BD
- 8.12.1 BD Company Information
- 8.12.2 BD Business Overview
- 8.12.3 BD Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 BD Molecular Microbiology Product Portfolio
- 8.12.5 BD Recent Developments
- 8.13 Foundation Medicine
- 8.13.1 Foundation Medicine Company Information
- 8.13.2 Foundation Medicine Business Overview
- 8.13.3 Foundation Medicine Molecular Microbiology Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Foundation Medicine Molecular Microbiology Product Portfolio
- 8.13.5 Foundation Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Molecular Microbiology Value Chain Analysis
- 9.1.1 Molecular Microbiology Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Molecular Microbiology Production Mode & Process
- 9.2 Molecular Microbiology Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Molecular Microbiology Distributors
- 9.2.3 Molecular Microbiology Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst